Cite
MLA Citation
David Viola et al.. “Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer.” Future oncology, vol. 9, 2013, pp. 1083–1092. http://access.bl.uk/ark:/81055/vdc_100136004224.0x000003